Bionpharma Inc. Divalproex Sodium Delayed-Release Tablets Recall
Announced 2026-07-29 · FDA
Bionpharma Inc. is recalling Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, in 500-tablet bottles distributed nationwide in the United States. The recall is due to the presence of foreign tablets/capsules. Lot# 704C003 has expiration date 12/31/2028.
| Brand | Bionpharma Inc. |
|---|---|
| Product | Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30. |
| Reason | Presence of Foreign Tablets/Capsules |
| Severity | moderate |
| Units affected | N/A |
| Distribution | US Nationwide. |
| Agency | FDA |
| Recall / campaign no. | Lot# 704C003, Exp. 12/31/2028 |
WHAT YOU SHOULD DO
- Do not use any tablets from Lot 704C003.
- Return the product or contact Bionpharma for instructions on disposal, replacement, or refund.
- If you have taken these tablets, consult your healthcare provider if you have any concerns.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.